Geron Corporation vs Portola Pharmaceuticals

Geron Corporation logo

Geron Corporation

Changing lives by changing the course of blood cancer

356 employees · est. 1992

VS
Portola Pharmaceuticals logo

Portola Pharmaceuticals

54 employees · est. 2003 · South San Francisco, United...

Geron Corporation is the older company (1992 vs 2003); Geron Corporation is the larger of the two.

Side-by-Side Comparison

Geron Corporation Portola Pharmaceuticals
Founded
1992 older 2003
Headquarters
Not tracked yet South San Francisco, United States
Employees
356 larger 54
Industry
Biopharma, Biotechnology, Health Care Biopharma, Biotechnology, Health and Wellness
Funding Stage
Post-IPO Equity Post-IPO Equity
Total Funding
$749.54M $1.31B
Funding Rounds
8 11
Services
Not tracked yet Research and Development in Rare Diseases, Clinical Trials Design and Execution, Patient-Centric Support Programs, Diagnostics Innovation, Business Development Partnerships, Discovery Partnerships
Target Customers
Not tracked yet Patients with Rare Diseases, Healthcare Providers in Rare Disease, Biopharmaceutical Partners, Regulatory Agencies, Medical Community Focused on Rare Disorders
Taxonomy
Blood CancerHematologic MalignanciesTelomerase InhibitorClinical TrialsPhase 3 TrialsInvestigational Medicine +7 BiopharmaceuticalCardiovascular DiseasesAutoimmune DiseasesThrombosisHematologic DisordersFactor Xa Inhibitor +9
Website
geron.com portola.com
Geron Corporation logo

About Geron Corporation

Geron Corporation is a pioneering biopharmaceutical company committed to revolutionizing the landscape of blood cancer treatment. Its relentless dedication to enhancing patient outcomes has led to the groundbreaking U.S. approval of the first telomerase inhibitor for certain adult patients with lowe...

Portola Pharmaceuticals logo

About Portola Pharmaceuticals

Portola Pharmaceuticals, founded in 2003 and headquartered in the United States, operates at the forefront of the biopharma and biotechnology sectors. Specializing in the discovery, development, and commercialization of novel therapeutics, the company is making significant strides in treating thromb...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Geron Corporation and Portola Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Geron Corporation or Portola Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Geron Corporation was founded in 1992, with 356 employees. Geron Corporation is a pioneering biopharmaceutical company committed to revolutionizing the landscape of blood cancer treatment. Its relentless dedication to enhancing patient outcomes has led to the. Portola Pharmaceuticals was founded in 2003, based in South San Francisco, United States, with 54 employees. Portola Pharmaceuticals, founded in 2003 and headquartered in the United States, operates at the forefront of the biopharma and biotechnology sectors. Specializing in the discovery, development, and c.
Geron Corporation has raised $749.54M and Portola Pharmaceuticals $1.31B. Latest stage: Geron Corporation Post-IPO Equity, Portola Pharmaceuticals Post-IPO Equity.
Both work in Biopharma and Biotechnology and list oncology among their focus areas.

Compare Geron Corporation with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Geron Corporation on 12 Sep 2024, and Portola Pharmaceuticals on 12 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes